Researchers from the Nuffield Department of Primary Care Health Sciences are part of a major new research initiative aimed at tackling critical workforce challenges in healthcare, particularly in underserved communities.
The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The \u00a391 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.
A survey at Vietnam's National Hospital for Tropical Diseases found 60% of hepatitis C patients unaware of how they contracted the disease, often diagnosed late. Globally, viral hepatitis causes 3,500 daily deaths, ranking second among infectious killers after tuberculosis.
A landmark study involving researchers from NDM\u2019s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
A new analysis by researchers at Oxford Population Health\u2019s Infectious Disease Epidemiology Unit has provided robust evidence in support of current World Health Organization (WHO) guidelines for treating pregnant women living with HIV. The study is published in Clinical Microbiology and Infection.
The Ineos Oxford Institute for antimicrobial research (IOI) has awarded \u00a35 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.
After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics \u2013 as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
International, national and local partners have been welcomed to the launch of the world\u2019s first centre dedicated to empowering global epilepsy research and care.
Researchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine vaccine vials to be retained in the supply chain. This technique can also differentiate genuine Covid-19 vaccine liquid from falsified vaccine surrogates.
Professor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM\u2019s Centre for Tropical Medicine and Global Health and the Big Data Institute, looks at potential ways to advance research on the impact of climate change on malaria and neglected tropical diseases (NTDs).
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has found that sotrovimab reduced the risk of death in patients hospitalised with COVID-19, but only in those with higher levels of the virus present in their blood. The results have been published on medRxiv and will be submitted to a peer-reviewed medical journal.
An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.
OUCRU Ha Noi and the National Hospital for Tropical Diseases (NHTD), under the guidance of the Department of Health, are collaborating to establish local hospital networks for Antimicrobial Stewardship (AMS) across Vietnam. This initiative, connecting district hospitals with provincial hospitals, leverages existing systems and resources to enhance AMS implementation and strengthen efforts against antimicrobial resistance (AMR).
National microbiology reference laboratories are central to global health and must be adequately funded, according to a viewpoint article published in The Lancet Digital Health by researchers at Oxford Population Health and the Invasive Respiratory Infection Surveillance (IRIS) Consortium.
An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.
![\"\"](\"https://www.globalhealth.ox.ac.uk/news/addressing-healthcare-workforce-challenges-with-new-research-partnership/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n